Linda Nolan's devastating health update as cancer treatment stops working
Linda Nolan has shared the heartbreaking news that her brain tumours have grown after her treatment stopped being effective. The singer from The Nolans was informed by her consultant that recent scans revealed an increase in the size of the two main tumours at the front and left side of her brain, along with a slight growth in smaller cancerous areas around them.
Last spring, Linda discovered that her secondary breast cancer had metastasised to her brain. She has been receiving regular treatments which initially reduced the tumours and then kept them stable. Despite the tumours not reaching their original size, this new development suggests that her current treatment is no longer working.
Mirror columnist Linda, aged 65, expressed her despair: "I sobbed when my consultant first told me. I know so many people are suffering and going through things, but I thought, just for once, could cancer just leave me alone? My heart sank," reports the Mirror.
READ MORE:ITV This Morning makes huge announcement about Cat Deeley and Ben Shephard's futures
READ MORE:Helen Flanagan reveals she and ex Scott Sinclair clashed over major decision involving their kids
She confessed to having suspected that something wasn't right, as her balance and memory were deteriorating, with her sisters needing to help her finish sentences.
"Maureen came with me to the appointment and my Macmillan Cancer support nurse was in the room, and I could just tell. I asked my consultant straight away: 'Has it spread? '
"When he told me, I immediately asked: 'What do we do now? '" recounted Linda, bravely sharing her battle with breast cancer since her first diagnosis in 2005. She received the all-clear, but the disease resurfaced years later in her hip in 2017 and then in her liver.
Linda has been undergoing regular immunotherapy since tumours were found in her brain last March, but she's now facing a beam of light with a new chemotherapy option that might control the progression of her cancer.
Starting on Wednesday 28, August, 2024, Linda will begin treatment with Enhertu, an innovative drug that's causing a stir due to its unavailability on the NHS in England for women with a different type of secondary breast cancer named HER2-low, sparking a contentious funding debate between NICE and pharmaceutical company AstraZeneca.
Although Linda faces HER2-positive secondary breast cancer and can access Enhertua contrasting situation to her HER2-low counterparts who are campaigning for the same rights in Englandthe drug is available in Scotland and has demonstrated the potential to extend lives.
Linda expressed her thoughts with heartfelt sincerity: "To be able to try a new drug is amazing, I just wish everyone could have this opportunity. To be able to try this is hope - it's a plan B not everyone is being allowed. To take this drug away from women is to take away their hope."
She remains resilient: "Thankfully, he is not saying 'we can't do anything for you'. We have more places to go. I am ready to try anything. I have done this before and I can do it again."
